Avestria Ventures

Avestria Ventures is a venture capital firm established in 2018 and located in San Francisco, California. The firm focuses on early-stage investments in sectors primarily related to women's health, including healthcare led by women, life sciences, digital health, health technology, and femtech. Avestria Ventures is recognized for its commitment to addressing significant opportunities within these areas, making it a notable player in the venture capital landscape.

Rachel Brannan

Investor

Tracy Dooley

Partner

Linda Greub

Co-Founder and Managing Partner

Stephanie Jin

Investor

Corinne Nevinny

Managing Director

8 past transactions

Rhinostics

Series A in 2022
Rhinostics is revolutionizing laboratory workflows to link sample to result seamlessly. The company’s products improve sample collection performance while removing costs and time compared to traditional collection and intake. The products bring new materials, new collection types, rapid accessioning and automation to remove caps and move samples into high throughput workflows with little human intervention.

Fogarty Innovation

Series A in 2021
Fogarty Innovation is a nonprofit organization established in 2007 and based in Mountain View, California, focused on advancing medical innovation to enhance human health. The organization supports promising innovators and researchers in transforming creative ideas into practical solutions for patient care. It provides mentorship and educational resources throughout the innovation process, facilitating access to intellectual, physical, and financial tools necessary to advance medical concepts from initiation to application. Fogarty Innovation operates two main programs: one that fosters innovation for startups and another aimed at educating the next generation of inventors. Through these initiatives, it aims to propel research and development in the medical field.

Raydiant Oximetry

Series A in 2021
Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.

Mae

Seed Round in 2021
Developer of a maternal health-tech software designed to connect black expectant mothers with critical resources to drive positive pregnancy outcomes. The company's platform features a free birth planning tool, and free fifteen-minute consults with doulas for interested expectant mothers, enabling medical professionals to elevate the standard of care, with a focus on improving maternal health outcomes.

AOA

Seed Round in 2021
AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Rhinostics

Seed Round in 2020
Rhinostics is revolutionizing laboratory workflows to link sample to result seamlessly. The company’s products improve sample collection performance while removing costs and time compared to traditional collection and intake. The products bring new materials, new collection types, rapid accessioning and automation to remove caps and move samples into high throughput workflows with little human intervention.

Alydia Health

Series C in 2020
Alydia Health is a medical device company working toward a solution to postpartum hemorrhage (PPH), the number one cause of maternal death. Our single-minded focus is to improve radically the treatment path for postpartum hemorrhage from the traumatic, life-altering condition that it is today. We are devoted to improving the lives of women around the world. Alydia Health was previously known as InPress Technologies, Inc.

Knowledge to Practice

Venture Round in 2020
Knowledge to Practice catalyzes and accelerates progress in postgraduate medical education. It offers self-directed learning solutions, self-assessment tools reveal knowledge gaps, content modules can be reviewed repeatedly, and more. The company was founded in 2014 and is based in Bethesda, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.